iBio, Inc. (IBIO) Total liabilities 2016–2025
iBio, Inc. (IBIO) total liabilities at each fiscal year-end, per SEC filings.
$8.3MFY2025 · since FY2016: $27.6M → $8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.3M | +12.1% |
| FY2024 | $7.4M | -71.3% |
| FY2023 | $25.8M | -28.1% |
| FY2022 | $35.9M | -6.5% |
| FY2021 | $38.4M | +2.2% |
| FY2020 | $37.6M | +33.6% |
| FY2019 | $28.1M | +4.5% |
| FY2018 | $26.9M | -0.6% |
| FY2017 | $27.1M | -1.7% |
| FY2016 | $27.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice